VistaGen Therapeutics Inc (VTGN)

[kwazeetech1]

I think the FDA big 'thumbs up' for the J&J drug was a huge sigh of relief and should give AV101 a positive feeling for its trial. I'm a little surprised the stock didn't get back to $2 on the news. Should see it get back near year highs as it gets closer to expected drug release dates if they don't need too much cash in the next few months, maybe even that $3 range before takeoff.